Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sanderson

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Molecular Cancer Therapeutics|October 7, 2015
BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose HomeostasisMichael P Sanderson, Joshua Apgar, Pilar Garin-Chesa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2015
Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid ArthritisSalah Mansour, Anna S Tocheva, Joseph P Sanderson, et al.
Harmful Algae|May 13, 2021
Spatiotemporal distribution of phycotoxins and their co-occurrence within nearshore watersMichelle D Onofrio, Todd A Egerton, Kimberly S Reece, et al.
Molecular Cancer Therapeutics|July 22, 2017
The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF TherapyMichael P Sanderson, Marco H Hofmann, Pilar Garin-Chesa, et al.
Toxicon: X|July 14, 2023
Co-occurrence of marine and freshwater phycotoxins in oysters, and analysis of possible predictors for managementSarah K D Pease, Todd A Egerton, Kimberly S Reece, et al.
Hepatology (Baltimore, Md.)|December 19, 2018
Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver CancerRoslin Y Docta, Tiago Ferronha, Joseph P Sanderson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 29, 2016
Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and FunctionBethany R Baumgart, Faye Wang, Jae Kwagh, et al.
Cancer Research|May 9, 2018
Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor StageTamara Aleksic, Nicki Gray, Xiaoning Wu, et al.
Oncoimmunology|February 1, 2020
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapyJoseph P Sanderson, Darragh J Crowley, Guy E Wiedermann, et al.
Cancers|June 13, 2025
LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast CancerXuemei Xie, Jangsoon Lee, Ganiraju C Manyam, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Molecular Cancer Therapeutics|October 7, 2015
BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose HomeostasisMichael P Sanderson, Joshua Apgar, Pilar Garin-Chesa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2015
Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid ArthritisSalah Mansour, Anna S Tocheva, Joseph P Sanderson, et al.
Harmful Algae|May 13, 2021
Spatiotemporal distribution of phycotoxins and their co-occurrence within nearshore watersMichelle D Onofrio, Todd A Egerton, Kimberly S Reece, et al.
Molecular Cancer Therapeutics|July 22, 2017
The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF TherapyMichael P Sanderson, Marco H Hofmann, Pilar Garin-Chesa, et al.
Toxicon: X|July 14, 2023
Co-occurrence of marine and freshwater phycotoxins in oysters, and analysis of possible predictors for managementSarah K D Pease, Todd A Egerton, Kimberly S Reece, et al.
Hepatology (Baltimore, Md.)|December 19, 2018
Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver CancerRoslin Y Docta, Tiago Ferronha, Joseph P Sanderson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 29, 2016
Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and FunctionBethany R Baumgart, Faye Wang, Jae Kwagh, et al.
Cancer Research|May 9, 2018
Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor StageTamara Aleksic, Nicki Gray, Xiaoning Wu, et al.
Oncoimmunology|February 1, 2020
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapyJoseph P Sanderson, Darragh J Crowley, Guy E Wiedermann, et al.
Cancers|June 13, 2025
LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast CancerXuemei Xie, Jangsoon Lee, Ganiraju C Manyam, et al.
Pageof 17